Skip to main content
Livermore
Livermore
ZHEN

Orbis Allan Gray Ltd

SEC CIK
0001663865
Latest filing
Aug 14, 2026

The latest 13F from Orbis Allan Gray Ltd covers Q2 2026 (filed Aug 14, 2026): 97 long positions worth $29.1B. The top 10 holdings make up 39.9% of the portfolio, and the largest is Corpay, Inc. (CPAY) at 6.2%. Livermore has 22 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
12
Est. +$844.2M
Added
45
Est. +$4.49B
Reduced
32
Est. −$2.22B
Sold out
6
Est. −$311.7M

Top 5 holdings

Share of this quarter's portfolio value

  1. CPAYCorpay, Inc.
    6.2%$1.80BHistory
  2. NBISNebius Group N.V.
    6.2%$1.79BHistory
  3. BKNGBooking Holdings Inc.
    4.4%$1.28BHistory
  4. QXOQXO, Inc.
    4.4%$1.28BHistory
  5. BRKRBruker Corp
    3.7%$1.08BHistory

Biggest buys

New and added positions, by estimated amount bought

  1. BKNGBooking Holdings Inc.
    +$953.1MAddedConverted for a 25-for-1 splitHistory
  2. INSMINSMED Inc
    +$448.2MAddedHistory
  3. SHELShell plc
    +$367.1MAddedHistory
  4. BROBrown & Brown, Inc.
    +$344.6MNewHistory
  5. PDDPDD Holdings Inc.
    +$275.3MAddedHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. BKNGBooking Holdings Inc.
    +3.09 pp1.3% → 4.4%History
  2. BROBrown & Brown, Inc.
    +1.18 pp0.0% → 1.2%History
  3. INSMINSMED Inc
    +0.93 pp1.3% → 2.2%History
  4. AALAmerican Airlines Group Inc.
    +0.90 pp0.1% → 1.0%History
  5. RYANRyan Specialty Holdings, Inc.
    +0.82 pp0.0% → 0.8%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. NBISNebius Group N.V.
    −$502.6MReducedHistory
  2. SWSmurfit Westrock plc
    −$365.2MReducedHistory
  3. PRAXPraxis Precision Medicines, Inc.
    −$315.6MReducedHistory
  4. WLKWestlake Corp
    −$234.3MReducedHistory
  5. AESAES Corp
    −$172.6MSold outHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. WLKWestlake Corp
    −2.09 pp2.6% → 0.5%History
  2. PRAXPraxis Precision Medicines, Inc.
    −1.60 pp3.4% → 1.8%History
  3. SWSmurfit Westrock plc
    −1.38 pp2.3% → 0.9%History
  4. AESAES Corp
    −0.73 pp0.7% → 0.0%History
  5. CXCemex SAB de CV
    −0.63 pp1.8% → 1.2%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$29.1B
+$5.39B (+22.7%) vs. prior quarter
Positions
97
+6 vs. prior quarter
Top 10 concentration
39.9%
Top 10 as share of value
Turnover
9.6%
Q2 2026, one quarter
Average holding period
10.7 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $29.1B (Q2 2026)

Q1 2021: $14.0BQ2 2021: $15.8BQ3 2021: $14.6BQ4 2021: $13.5BQ1 2022: $13.7BQ2 2022: $12.4BQ3 2022: $12.2BQ4 2022: $12.6BQ1 2023: $12.7BQ2 2023: $14.0BQ3 2023: $13.9BQ4 2023: $15.9BQ1 2024: $16.7BQ2 2024: $16.1BQ3 2024: $18.9BQ4 2024: $18.6BQ1 2025: $17.5BQ2 2025: $20.6BQ3 2025: $23.3BQ4 2025: $23.9BQ1 2026: $23.7BQ2 2026: $29.1B
Q1 2021Q2 2026
13F filings of Orbis Allan Gray Ltd by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 14, 202697$29.1BCPAYNBISBKNGvs. Q1 2026SEC
Q1 2026May 15, 202691$23.7BCPAYQXONBISvs. Q4 2025SEC
Q4 2025Feb 17, 202689$23.9BQXOCPAYUNHvs. Q3 2025SEC
Q3 2025Nov 14, 202586$23.3BQXONBISCPAYvs. Q2 2025SEC
Q2 2025Aug 14, 202578$20.6BQXOCPAYELVvs. Q1 2025SEC
Q1 2025May 15, 202578$17.5BQXOCPAYELVvs. Q4 2024SEC
Q4 2024Feb 14, 202584$18.6BQXOCPAYUNHvs. Q3 2024SEC
Q3 2024Nov 14, 202481$18.9BQXOUNHCPAYvs. Q2 2024SEC
Q2 2024Aug 14, 202477$16.1BUNHCPAYIBKRvs. Q1 2024SEC
Q1 2024May 15, 202472$16.7BCPAYUNHIBKRvs. Q4 2023SEC
Q4 2023Feb 14, 202474$15.9BCPAYGXOGPNvs. Q3 2023SEC
Q3 2023Nov 14, 202377$13.9BCPAYGXOGPNvs. Q2 2023SEC
Q2 2023Aug 14, 202374$14.0BCPAYGXOGPNvs. Q1 2023SEC
Q1 2023May 15, 202373$12.7BCPAYGXOGPNvs. Q4 2022SEC
Q4 2022Feb 14, 202379$12.6BCPAYGXOGPNvs. Q3 2022SEC
Q3 2022Nov 14, 202273$12.2BCPAYGPNSHELvs. Q2 2022SEC
Q2 2022Aug 15, 202274$12.4BCPAYGPNBTIvs. Q1 2022SEC
Q1 2022May 16, 202275$13.7BUNHCPAYGPNvs. Q4 2021SEC
Q4 2021Feb 14, 202263$13.5BUNHGXOXPOvs. Q3 2021SEC
Q3 2021Nov 15, 202162$14.6BNTESXPOGXOvs. Q2 2021SEC
Q2 2021Aug 16, 202165$15.8BNTESXPOCMCSAvs. Q1 2021SEC
Q1 2021May 17, 202163$14.0BNTESXPOELV–SEC